Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23395119

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2013 Mar
First author
Vora A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Mar;14(3):178-9. doi: 10.1016/S1470-2045(13)70001-9.
    note
    Source null
    related pmid
    23402706
    relationship
    Comment in

Authors and identifiers

  1. name
    Vora A
    type
    Author
  2. name
    Goulden N
    type
    Author
  3. name
    Wade R
    type
    Author
  4. name
    Mitchell C
    type
    Author
  5. name
    Hancock J
    type
    Author
  6. name
    Hough R
    type
    Author
  7. name
    Rowntree C
    type
    Author
  8. name
    Richards S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Vora A
    type
    Author
  2. name
    Goulden N
    type
    Author
  3. name
    Wade R
    type
    Author
  4. name
    Mitchell C
    type
    Author
  5. name
    Hancock J
    type
    Author
  6. name
    Hough R
    type
    Author
  7. name
    Rowntree C
    type
    Author
  8. name
    Richards S
    type
    Author
bibliography ids
  1. nci-bib-e0ddf85946978f1541ccdb1e
book metadata
content sha256
75cddc1424ba609c712640cc5f571168f0425016687582df06483c4a390e5ea5
document type
citation
dois
  1. 10.1016/S1470-2045(12)70600-9
electronic publication date
display
2013 Feb 7
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23395119
immutable id
pubmed:23395119@75cddc1424ba609c712640cc5f571168f0425016687582df06483c4a390e5ea5
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
199-209
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Mar;14(3):178-9. doi: 10.1016/S1470-2045(13)70001-9.
    note
    Source null
    related pmid
    23402706
    relationship
    Comment in
outcomes validated
false
pmid
23395119
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
6974438ca6e34fd615bc58ae87d911e57fcd39f025956086cb448911709855b5
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 Mar
precision
month
year
2013
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23395119/
title
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

Preserved source evidence · Not medical advice